即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1092540-56-1 | 货号 | BCP03513 |
中文名 | Deuterated Atazanivir-D3-1 | ||
英文名 | Deuterated Atazanivir-D3-1 | ||
中文别名 | |||
英文别名 | CTP-518;CTP518;CTP 518; | ||
SMILES | |||
化学名称 | |||
分子式 | C38H37D15N6O7 | 分子量 | 719.96 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Atazanivir-D3-2 is an azapeptide derivative and a HIV protease inhibitor. Atazanivir-D3-2 is a deuterium-containing agent. Atazanivir-D3-2 displays a shorter half life than atazanavir, as well as Atazanivir-D3-1 and Atazanivir-D3-3. Atazanavir sulfate prevents the formation of mature HIV virions in HIV-1 infected cells by selectively inhibiting the virus-specific processing of certain polyproteins (viral Gag and Gag-Pol). Atazanavir sulfate is currently approved for the treatment of HIV infection. Atazanavir is contraindicated for co-administration with medicines that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. Due to inhibitory effects of atazanavir on CYP3A, CYP2C8, and UGTIAl, caution is advised when prescribing. Common adverse events associated with atazanavir include hyperbilirubinemia, rash, nausea, headache, mid jaundice/sclcral icterus. |
Tags:Deuterated Atazanivir-D3-1 供应商,Deuterated Atazanivir-D3-1 购买,Deuterated Atazanivir-D3-1 生产,Deuterated Atazanivir-D3-1 批量,Deuterated Atazanivir-D3-1 供应,Deuterated Atazanivir-D3-1 订购,Deuterated Atazanivir-D3-1 采购